Protalix BioTherapeutics, Inc. Interest Expense, Debt, Excluding Amortization
Protalix BioTherapeutics, Inc. (PLX) reported Interest Expense, Debt, Excluding Amortization of $3.10 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebtExcludingAmortization · last filed 2016-03-08
- Protalix BioTherapeutics, Inc. interest expense, debt, excluding amortization for the quarter ending 2013-12-31 was $784.00K.
- Protalix BioTherapeutics, Inc. interest expense, debt, excluding amortization for the quarter ending 2013-09-30 was $104.00K.
- Protalix BioTherapeutics, Inc. interest expense, debt, excluding amortization for fiscal 2015 was $3.10M, a 0.00% change from fiscal 2014.
- Protalix BioTherapeutics, Inc. interest expense, debt, excluding amortization for fiscal 2014 was $3.10M, a 249.66% increase from fiscal 2013.
- Protalix BioTherapeutics, Inc. interest expense, debt, excluding amortization for fiscal 2013 was $888.00K.
| Period end | Interest Expense, Debt, Excluding Amortization 3 month | Interest Expense, Debt, Excluding Amortization 6 month | Interest Expense, Debt, Excluding Amortization 9 month | Interest Expense, Debt, Excluding Amortization 12 month |
|---|---|---|---|---|
| 2015-12-31 | $3.10M 10-K · filed 2016-03-08 | |||
| 2014-12-31 | $3.10M 10-K · filed 2016-03-08 | |||
| 2013-12-31 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $888.00K derived: sum of 2 quarters · filed 2016-03-08 | $888.00K 10-K · filed 2016-03-08 | |
| 2013-09-30 | $104.00K 10-Q · filed 2013-11-07 | $104.00K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |